KPTI Stock Analysis: Buy, Sell, or Hold?
KPTI - Karyopharm Therapeutics Inc.
$1.96
0.14 (7.69%)
▲
5d:
-2.97%
30d:
-72.36%
90d:
-75.68%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When KPTI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: KPTI shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: KPTI shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: KPTI is currently trading at $1.96, which is considered oversold relative to its 30-day fair value range of $2.07 to $8.62.
Technical Outlook: Technically, KPTI is in a downtrend. Immediate support is located at $1.79, while resistance sits at $2.18. The stock is showing strong short-term momentum, up 7.7% recently.
Market Sentiment: KPTI scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.25 (+269.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KPTI is in a downtrend. Immediate support is located at $1.79, while resistance sits at $2.18. The stock is showing strong short-term momentum, up 7.7% recently.
Market Sentiment: KPTI scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.25 (+269.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.07 -
$8.62
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
100.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.7%)
- BULLISH: Trading 269.9% below Wall St target ($7.25)
- WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.07 -
$8.62
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.79
Resistance Level
$2.18
Current Trend
Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.70
Wall Street Target
$7.25
(+269.9%)
Revenue Growth (YoY)
-11.9%
Profit Margin
-153.3%
Share & Embed Analysis
Last updated: August 24, 2026 3:38 AM ET
Data refreshes hourly during market hours. Next update: 4:38 AM
Data refreshes hourly during market hours. Next update: 4:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KPTI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Reshma Rangwala
SELL
449 shares
2026-04-21
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 33 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1173 | 43 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$840 | 34 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$281 | 55 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 49 HOLD |
